GENENTECH, INC for GENENTECH INC

Trade (domestic/foreign) TRD

Trade Policy Issues. Trade Negotiations.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

General tax issues. H.R. 1, Tax Cuts and Jobs Act. Tax Reform Act of 2017 - Issues related to tax reform

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1 (115th)

Medical/Disease Research/Clinical Labs MED

Issues relating to drug pricing

Contacted: Health & Human Services, Dept of (HHS); SENATE; White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark CPT

Intellectual property and process patent issues. General IP issues. Patent litigation reform.

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office; HOUSE OF REPRESENTATIVES

Health Issues HCR

Medicare payment policies for Part B drugs. HR 4710, 340B Pause Act and other issues relating to the 340B Drug Discount Program CHIP reauthorization and Medicare Extenders package. Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 S.204/H.R.878, Trickett Wendler Right to Try Act of 2017 H.J.Res.123, Making further continuing appropriations for fiscal year 2018, and for other purposes H.J.Res.124, Making further additional continuing appropriations for fiscal year 2018, and for other purposes H.R.1370, Further Additional Continuing Appropriations Act, 2018 Pharmaceutical benefits for TRICARE beneficiaries Issues related to pharmaceutical drug pricing Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives. Pharmaceutical distribution and supply chain security American Health Care Act of 2017 Issues relating to biosimilar reimbursement

Contacted: SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4710 (115th), H.R. 878 (115th), H.J.Res. 123 (115th), H.R. 1370 (115th), H.J.Res. 124 (115th), S. 204 (115th)

Medicare/Medicaid MMM

Medicare payment policies for Part B drugs. HR 4710, 340B Pause Act and other issues relating to the 340B Drug Discount Program CHIP reauthorization and Medicare Extenders package. Issues related to Medicare and Medicaid coverage and reimbursement; Issues relating to biosimilar reimbursement; Issues related to RX drug pricing. Medicare payment for inpatient antimicrobial therapy.

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office

Bills named: H.R. 4710 (115th)

Budget/Appropriations BUD

Issues related to FDA and HHS program funding in the FY18 Labor, Health and Human Services, and Education and Related Agencies, and FY18 Agriculture, Rural Development, Food and Drug Administrations, Related Agencies Appropriation bills

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office

Pharmacy PHA

Drug Pricing Issues Prescription Drug User Fee Act reauthorization. HR 4710, 340B Pause Act and other issues relating to the 340B Drug Discount Program

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; SENATE

Bills named: H.R. 4710 (115th)